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NMR Chemistry Analysis of Red Blood Cell 
Constituents in Normal Subjects and Lithium-Treated 
Psychiatric Patients 
Edward F. Domino, Robert R. Sharp, Steven Lipper, 
Christian L. Ballast, Beverly Delidow, and Michael R. Bronzo 
Red blood cells from 18 lithium carbonate-treated patients with bipolar affective disorder 
and 12 normal volunteers were analyzed using 1H-nuclear magnetic resonance (NMR) 
spectroscopy. The spectra were analyzed for alanine, adenosine triphosphate (ATP), 
choline, 2,3-diphosphoglycerol, glucose, glutathione, glycine, and lactate. Significant 
elevations of choline and lactate were found in the lithium-treated patients compared 
with normal, unmedicated subjects. The elevation of lactate due to anaerobic metabolism 
in the red blood cells was further investigated via fluorometric analysis and appears to 
be caused by blood standing at room temperature. The observed increases in red blood 
cell choline are sufficiently high and statistically significant to warrant additional studies 
on the dramatic effects of lithium on this red cell metabolite, which might be important 
for an understanding of its mechanism of action in psychiatric disorders. 
Introduction 
Lithium salts are currently the most effective treatment for manic-depressive patients, yet 
the mechanism for the therapeutic action of lithium ion is unknown. Many biochemical 
changes appear to result from lithium treatment. Lingsch and Martin (1976) observed 
that the red blood cells of humans treated with lithium show an apparent "irreversible" 
reduction of the flux of 14C-choline. Paradoxically, many investigators have reported an 
increase of the choline levels in the red blood cells following lithium treatment (Jope et 
al. 1978; Ehrlich and Diamond 1980; Domino et al. 1981; Hanin et al. 1981). 
In addition to changes in red blood cell choline levels, Shea et al. (1981) and Pomara 
et al. (1983) reported that glycine accumulates in the human red cells following chronic 
lithium treatment. Although lithium treatment alters the concentrations of these cellular 
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metabolites, no acceptable biological marker of lithium therapy exists. This study used 
nuclear magnetic resonance (NMR) analysis of the red blood cells from lithium-treated 
patients to provide a simultaneous determination of several intracellular constituents, 
thereby allowing a greater probability of finding further metabolic changes induced by 
chronic lithium treatment and possibly a clinically useful marker of lithium therapy. 
Methods 
Human use approval for this study was obtained from the University of Michigan Medical 
Center Committee to Review Grants for Clinical Research Involving Human Beings. 
Venous blood from 12 normal volunteers was drawn into 10-ml heparinized vacutainers 
and placed immediately on ice. Blood was also drawn from 18 lithium-treated psychiatric 
patients who met the DSM-III criteria (Spitzer et al. 1978) for bipolar affective disorders. 
Venous blood from patients was also drawn into 10-ml heparinized vacutainers, but a 
variable amount of time (from immediately to 1 hr) occurred between the blood being 
drawn and being put on ice. The patients consisted of 16 women and 2 men, who had 
lithium therapy of duration ranging from 1 month to 10 years. The patients had plasma 
lithium values ranging from 0.27 to 1.33 meq/liter red blood cells, with the average being 
0.87 _+ 0.07 meq/liter red blood cells. The majority of these patients were euthymic at 
the time the blood sample was drawn, primarily for assessing their lithium levels on 
maintenance therapy. 
The blood samples were centrifuged for 10 min (600-900 x g), and the plasma was 
decanted for lithium determination. An equal volume of 10% trichloroacetic acid (TCA) 
was added to the red blood cells to denature protein, which was removed as a precipitate 
after centrifuging (15-20 min, 600-900 x g). The pH of the supematant was adjusted 
to 6.5-7.0 with 2 M Na2CO3, and a small amount of Chelex (10% w/w) was added to 
remove the paramagnetic ions, chiefly Fe 3 ÷ which, if not removed, would broaden the 
NMR peaks. The solution was stirred for several hours, then frozen in liquid nitrogen 
and lyophilized overnight. The remaining precipitate was brought up to 600 I~1 with D20 
and 2,2-dimethyl-2-sila-pentane-5-sulfonic acid (DSS) added as the internal standard to 
a final concentration of 0.5 mM. The tH-NMR spectrum of the solutions was taken on 
a Bruker WM 360 NMR spectrometer. 
NMR peak identification was established by (1) reference spectra of known metabolites 
and (2) additions of reference compounds to prepared red blood cell lyophilates. The 
NMR peaks were quantitated by comparing peak integrals with the integral of the DSS 
standard and accounting for the different number of protons represented by the different 
NMR peaks. The concentration of the components in the red blood cells was calculated 
using the approximation of 11.4 x 109 cells/ixl packed red blood cells. 
In addition, red blood cell lactate levels also were analyzed over time using an enzymic 
fluorometric analysis by the method of Lloyd et al. (1978). Blood was drawn from two 
normal volunteers and two euthymic bipolar patients on chronic lithium. The blood was 
subjected to three different treatments: (1) placed immediately on ice; (2) placed im- 
mediately at room temperature; (3) placed on ice followed by warming to room temper- 
ature. The blood was centrifuged at 2500 rpm for 5 min to pack the red blood cells. At 
15-min intervals, 0.5-ml samples of the packed red blood cells were denatured by addition 
to 0.5 ml concentrated perchloric acid, followed by 1 min of vortexing. These solutions 
were then fluorometrically analyzed for lactate. 
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A typical NMR spectrum of the lyophilates of red blood cells of a normal control and a 
lithium-treated patient are shown in Figure 1. The peak assignments are as illustrated. 
The alanine peak was undetectable in about half the samples. The glycine peak was 
obscured by the many small peaks from 3.2-4 ppm, which were attributed to glucose. 
Glycine was therefore difficult to quantify. 
Mean ___ SD data for a maximum of 18 patients and 9 normal volunteers are presented 
in Table 1, along with literature values. Compared with previously published literature, 
the mean concentrations of red blood cell lactate were too high and glucose too low, 
suggesting a possible artifact of anaerobic metabolism. The values for glutathione, 2,3- 
diphosphoglycerol (2,3-DPG), glucose, alanine, glycine, and adenosine triphosphate (ATP) 
were not significantly different for lithium-treated patients and normal volunteers by 
Student t-test. In addition, except for glucose, they were roughly comparable to those 
previously described in the literature. The mean red blood cell choline level in the lithium- 
treated patients was more than five times greater than the mean red blood cell choline 
level in the normal volunteers. Lactate levels also were significantly elevated in lithium- 
treated patients compared with the normal volunteers. 
Figure 1. ]H-NMR spectra of red blood cell lyophilates. Representative ~H-NMR spectra are given 
for both a normal volunteer and a lithium carbonate-treated patient. The peaks identified on the 
spectra are only those used for metabolite quantitation. The alanine peak is virtually absent in both 
these spectra. The many small peaks from 3.2 to 4.0 ppm are due to glucose; however, only the 
peak at 5.25 ppm was used to quantify glucose. The peaks of each spectrum were compared with 
the internal standard (DDS) for quantification. 
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Table 1. Blood Constituents Measured in Normal Volunteers and Li-Treated Patients 
Previously reported 
Normal Lithium-treated concentrations 
Substance volunteers patients for normals References 
Li - -  0.88 ± 0.08 (18) - -  
Lactate Q 0.76 ± 0.11 (9) b 1.40 ± 0.11 (18) 0.372 ± 0.073 Foster et al. 1978 
Glutathione 1.13 --- 0.16 (9) 0.81 ± 0.08 (18) 2.33 ± 0.13 Hagenfeldt et al. 1978a 
Choline a 0.05 --- 0.01 (8) 0.26 ± 0.04 (18) 0.010--0.100 Domino et al. 1981 
2,3-DPG 3.29 ± 0.37 (9) 2.79 ± 0.17 (18) 3.6-5.0 Vanderheiden 1961 
Glucose 0.54 -+ 0.08 (9) 0.65 - 0.08 (16) 2.88 ± 0.44 Foster et al. 1978 
Alanine 0.19 ± 0.04 (3) 0.36 ± 0.08 (6) 0.183-0.363 Foster et al. 1978 
Glycine 0.32 ± 0.05 (6) 0.47 ± 0.11 (5) 0.258-0.500 Hagenfeldt et al. 1978b 
ATP 0.05 ± 0.07 (9) 0.48 ± 0.05 (18) 0.452 Bartlett and Marlow 1953 
°p < 0.05, two-tailed t-test. 
bAll figures are expressed in mmol/liter of packed red blood cells. The numbers in parentheses indicate the number of 
subjects included, as NMR peaks could not be adequately separated for each spectrum. 
For further analysis, the patients were divided into two groups: (1) three patients who 
had been on lithium carbonate treatment less than 4 months but more than 1 month, and 
(2) 12 patients who had been on lithium carbonate treatment more than 4 months. Three 
patients were eliminated because the duration of their lithium therapy was unclear. This 
analysis appears in Table 2. The lactate levels for patients in the short-term lithium 
treatment group were significantly different (p < 0.05) from those in the long-term lithium 
treatment group; the lactate levels for both the long- and short-treatment groups were 
significantly different from the normal group's (p < 0.05). 
Inasmuch as anaerobic metabolism can elevate lactate levels, additional studies were 
done in which red blood cells were allowed to stand in ice as well as at room temperature. 
Blood lactate was measured fluorometrically in the latter study. Significant and similar 
increases in red cell lactate levels were found as expected when the red blood cells from 
two normal subjects and two lithium-treated patients were allowed to stand at room 
temperature. Some typical time analyses of red blood cell lactate levels as a function of 
Table 2. RBC Constituents in Li-Treated Patients as a Function of  Duration of  Treatment 
Group 1 
Treatment more than 1 month 
Substance and less than 4 months 
Group 2 
Treatment more than 4 months 
Lactate ° 1.85 ± 0.32 (3) b 1.35 ± 0.10 (12) 
GSH 0.92 ± 0.37 (3) 0.83 ± 0.09 (12) 
Choline 0.23 ± 0.06 (3) 0.30 ± 0.06 (12) 
2,3-DPG 2.88 ± 0.09 (3) 2.91 ± 0.17 (12) 
Glucose 0.81 ± 0.35 (2) 0.64 ± 0.11 (11) 
Aianine 0.50 (1) 0.25 ± 0.06 (4) 
Glycine - -  (0) 0.47 ± 0.11 (5) 
ATP 0.47 ± 0.01 (3) 0.52 ± 0.06 (12) 
ap < 0.05, two-tailed t-test. 
bAll figures are expressed in retool/liter of packed red blood cells. The numbers in parentheses indicate the number of 
subjects included, as NMR peaks could not be adequately separated for each spectrum. 
RBC Constituents in Li-Treated Patients BIOL PSYCHIATRY 1281 
1985;20:1277-1283 
LACTATE 











. Curve 2 1 
Li Treated | 
iCe-room tem nJ~%4 
f t • A ~  • 
2 dr 




| # I ~ I ! 
15 30 45 75 110 
TINE (mira) 
Figure 2. Effect of environmental temperature on red blood cell lactate levels. Lactate levels were 
assayed fluorometrically. (1 and 3) Blood from a normal volunteer kept at room temperature. (2) 
Blood from a lithium-treated patient left on ice for 49 rain, then warmed to room temperature and 
left at room temperature. (4) Blood from a normal volunteer kept in ice. 
environmental temperature are shown in Figure 2. The increase in red blood cell lactate 
was similar in both the normal volunteers (2) and lithium-treated patients (2). Hence, the 
increase in red blood cell lactate levels observed by NMR analysis in the lithium-treated 
patients could have been due to differences in blood standing at room temperature. 
Discussion 
The choline increase reported for lithium-treated patients using the NMR method in this study 
was roughly a fivefold increase, compared to a roughly 20-fold increase for a gas chromato- 
graphic method also used in this lab (Domino et al. 1981). This discrepancy is probably due 
to differences in individual patient variability and chemical methodologies, particularly 
differences in extraction before analysis. It has been previously reported that enormous dif- 
ferences in red cell choline are frequently observed even in patients with similar doses and 
duration of lithium therapy (Domino et al. 1981). 
It should be noted that in a previous NMR study of red blood cell metabolism, Brown et 
al. (1977) reported that a peak at approximately 2.7 ppm was acetylcholine. In subsequent 
studies, this error in NMR peak assignment has been corrected (Jones and Kuchel 1980). 
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Shea et al. (1981) as well as Pomara et al. (1983) reported a significant increase (about 
30%) in red blood cell glycine in lithium-treated patients. Shea et al. reported this increase 
in normal volunteers compared to lithium-treated patients, whereas Pomara et al. reported 
a slightly lower increase for patients before lithium treatment compared to during lithium 
treatment. Using the NMR methodology described in this article, no differences in glycine 
levels were found between normal volunteers and lithium-treated patients. However, it 
should be noted that the glycine peak was one of the most difficult to distinguish and, 
as a result, glycine values were obtained for only 5 of 18 lithium-treated patients and 6 
of 9 normal volunteers, thus distorting the results. 
The observed increase in red cell lactate for lithium-treated patients versus normal 
volunteers deserves further comment. As the blood from the lithium-treated patients may 
have stood at room temperature for an indeterminant amount of time (from less than 1 
min up to 1 hr), the increased lactate levels are probably due to normal anaerobic glucose 
metabolism. The fluorometric analysis showed neither a difference in lactate levels be- 
tween the normal volunteers and lithium-treated patients, nor a difference between the 
increases in lactate with time. One finding that still remains unexplained is that patients 
treated longer than 1 month but less than 4 months with lithium had slightly larger red 
blood cell lactate levels. 
Obviously, further studies on red cell lactate levels in lithium-treated patients should 
be performed. Nevertheless, on the basis of this preliminary study, one must conclude 
that the increase in red blood cell lactate is probably an artifact due to blood standing 
for even a short period of time at room temperature. Future studies must keep in mind 
differences between aerobic and anaerobic metabolism and the effect of environmental 
temperature on red blood cell constituents. 
The authors would like to acknowledge the help of Drs. Greden, Haraharahan, Richie, and Martin in this study. 
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